Catalyst Wire Dossier Catalyst Wire Dossier

Regenecare Wound Gel

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Regenecare Wound Gel, covering 2013-09-20 to 2013-09-20. Get the full timeline:

Most recent: Clinical Trial Update: Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer [NA]

See pricing